CF vs NTR vs CTVA
161 measures in 16 categories, one definition each, computed from filings and market data.
CF83.5
CF Industries Holdings, Inc.
Basic Materials · Agricultural Inputs
$120.85 +0.95%$18.3B mkt cap
Score DNA
Price, rebased to 100 three years ago
CF NTR CTVA · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 0 | 0 | 2 |
| Last Congress purchase | — | — | 2026-09-04 |
| 13F net change in holders | +51 | −9 | +17 |
| ETFs adding shares, 30d | 910 | 20 | 1,017 |
| ETFs trimming, 30d | 791 | 15 | 807 |
| Net ETF funds, 30d | +119 | +5 | +210 |
Valuation
16 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| P/E (TTM) | 8.7x
29th
|
14.3x
43rd
|
8.5x
14th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.36 | — | 1.66 |
| Price / sales | 2.4x
100th
|
1.2x
62nd
|
0.5x
12th
|
| Price / book | 3.2x
86th
|
1.3x
71st
|
0.3x
0th
|
| Price / tangible book | 6.0x
83rd
|
2.5x
50th
|
8.5x
100th
|
| Price / free cash flow | 9.6x
29th
|
16.1x
86th
|
13.7x
57th
|
| Price / operating cash flow | 6.1x
25th
|
8.0x
75th
|
7.1x
62nd
|
| Enterprise value | $19.4B
88th
|
$45.8B
100th
|
$11.1B
62nd
|
| EV / sales | 2.5x
88th
|
1.6x
75th
|
0.6x
0th
|
| EV / EBITDA | 4.7x
14th
|
7.3x
86th
|
3.4x
0th
|
| EV / EBIT | 5.9x
14th
|
11.8x
57th
|
5.5x
0th
|
| EV / free cash flow | 10.2x
14th
|
21.7x
71st
|
17.7x
57th
|
| Earnings yield | 11.5%
75th
|
7.0%
62nd
|
11.7%
88th
|
| FCF yield | 10.4%
75th
|
6.2%
25th
|
7.3%
50th
|
| Operating cash flow yield | 16.3%
75th
|
12.5%
25th
|
14.1%
38th
|
| Graham number (per share) | $107.06
100th
|
$77.53
67th
|
$35.59
33rd
|
Profitability (TTM)
12 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| Gross margin | 42.5%
88th
|
31.0%
50th
|
48.5%
100th
|
| EBITDA margin | 53.8%
100th
|
22.3%
75th
|
18.2%
50th
|
| Operating margin | 38.1%
100th
|
14.4%
62nd
|
16.8%
75th
|
| EBIT margin | 42.3%
100th
|
13.9%
75th
|
11.2%
62nd
|
| Net margin | 27.1%
100th
|
8.4%
62nd
|
5.7%
50th
|
| NOPAT margin | 30.7%
100th
|
11.0%
62nd
|
11.6%
75th
|
| FCF margin | 24.7%
100th
|
7.5%
50th
|
3.5%
12th
|
| Operating cash flow margin | 38.5%
100th
|
15.0%
62nd
|
6.8%
25th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
8.4%
100th
|
| SG&A / revenue | 4.8%
12th
|
15.0%
50th
|
20.4%
88th
|
| Stock comp / revenue | 0.6%
43rd
|
— | 0.0%
0th
|
| Effective tax rate | 19.5%
25th
|
23.8%
50th
|
30.7%
62nd
|
Returns on capital
11 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| ROE (on average equity) | 39.2%
86th
|
9.3%
71st
|
4.0%
29th
|
| ROA | 14.6%
88th
|
4.4%
75th
|
2.4%
50th
|
| ROIC | 34.5%
100th
|
8.2%
62nd
|
7.5%
50th
|
| ROCE | 22.9%
100th
|
9.3%
62nd
|
6.5%
38th
|
| Return on tangible assets | 22.7%
100th
|
7.3%
62nd
|
4.8%
38th
|
| Cash ROIC (OCF / invested capital) | 43.3%
100th
|
11.2%
38th
|
4.4%
25th
|
| Gross profitability (GP / assets) | 21.8%
88th
|
16.3%
38th
|
20.3%
75th
|
| ROIC, 3-yr average | 21.6%
100th
|
4.2%
50th
|
4.5%
75th
|
| ROIC, 5-yr average | 29.5%
100th
|
8.6%
57th
|
5.3%
29th
|
| ROE, 5-yr average | 35.8%
86th
|
11.6%
57th
|
4.6%
29th
|
| Incremental ROIC | 123.8%
57th
|
— | 221.4%
71st
|
Growth
17 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| Revenue growth (TTM YoY) | 20.0%
100th
|
8.4%
62nd
|
3.7%
25th
|
| Revenue growth (QoQ) | 11.9%
50th
|
78.8%
100th
|
30.1%
88th
|
| Revenue CAGR, 3 yr | -3.9%
50th
|
-5.6%
25th
|
0.5%
100th
|
| Revenue CAGR, 5 yr | 11.0%
88th
|
4.3%
50th
|
3.7%
38th
|
| Gross profit CAGR, 3 yr | -6.1%
75th
|
-8.1%
62nd
|
5.4%
88th
|
| Operating income CAGR, 3 yr | -7.1%
71st
|
-14.9%
43rd
|
14.2%
86th
|
| Net income growth (TTM YoY) | 61.2%
67th
|
74.2%
83rd
|
-28.0%
17th
|
| Net income CAGR, 3 yr | -4.2%
67th
|
-13.7%
33rd
|
3.0%
100th
|
| EPS growth (TTM YoY) | 70.9%
67th
|
77.1%
83rd
|
-26.7%
17th
|
| EPS CAGR, 3 yr | 3.7%
83rd
|
-12.8%
33rd
|
5.1%
100th
|
| EPS CAGR, 5 yr | 45.3%
100th
|
24.0%
83rd
|
-1.7%
50th
|
| FCF growth (TTM YoY) | 6.9%
50th
|
23.2%
83rd
|
-75.8%
0th
|
| FCF CAGR, 3 yr | -11.4%
60th
|
-20.1%
20th
|
— |
| Operating cash flow CAGR, 3 yr | -2.7%
86th
|
-15.4%
43rd
|
— |
| Book value CAGR, 3 yr | 7.9%
100th
|
1.8%
71st
|
0.7%
57th
|
| Dividend CAGR, 3 yr | 5.1%
71st
|
0.7%
29th
|
3.3%
57th
|
| Sustainable growth rate | 33.3%
100th
|
5.2%
50th
|
2.1%
33rd
|
Margin history & stability
7 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| Gross margin, 3-yr average | 38.5%
88th
|
29.8%
50th
|
45.7%
100th
|
| Operating margin, 3-yr average | 33.5%
100th
|
10.5%
50th
|
14.8%
75th
|
| Net margin, 3-yr average | 21.7%
100th
|
5.5%
62nd
|
6.4%
75th
|
| FCF margin, 3-yr average | 19.0%
88th
|
8.0%
38th
|
9.2%
50th
|
| Revenue stability (0-1) | 0.25
38th
|
0.07
12th
|
0.70
88th
|
| Earnings stability (0-1) | 0.04
12th
|
0.08
38th
|
0.11
50th
|
| Margin stability (0-1) | 0.73
25th
|
0.92
88th
|
0.93
100th
|
Liquidity (latest quarter)
7 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| Cash & short-term investments | $2.5B
100th
|
$921.0M
75th
|
$2.4B
88th
|
| Net cash (− = net debt) | −$1.1B
75th
|
−$11.8B
0th
|
−$2.5B
50th
|
| Working capital | $3.0B
75th
|
$4.5B
88th
|
$5.6B
100th
|
| Current ratio | 4.86
88th
|
1.39
25th
|
1.52
38th
|
| Quick ratio | 4.32
100th
|
0.86
25th
|
1.10
50th
|
| Cash ratio (cash + ST investments / current liabilities) | 3.21
88th
|
0.08
25th
|
0.22
50th
|
| Defensive interval (days) | 3,443 days
88th
|
751 days
62nd
|
736 days
50th
|
Leverage & solvency (latest quarter)
13 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| Total debt | $3.6B
50th
|
$12.7B
100th
|
$4.9B
75th
|
| Debt / equity | 0.63
71st
|
0.49
29th
|
0.19
14th
|
| Net debt / equity | 0.20
29th
|
0.46
57th
|
0.10
14th
|
| Debt / assets | 23.9%
50th
|
23.8%
38th
|
11.7%
12th
|
| Debt / capital | 38.6%
71st
|
32.9%
29th
|
16.2%
14th
|
| Debt / EBITDA | 0.87
14th
|
2.03
43rd
|
1.50
29th
|
| Net debt / EBITDA | 0.27
14th
|
1.88
71st
|
0.77
29th
|
| Interest coverage (EBIT / interest) | 19.2x
88th
|
5.3x
50th
|
11.4x
62nd
|
| Cash interest coverage | 17.4x
88th
|
5.7x
50th
|
6.9x
62nd
|
| Debt payback (years of OCF) | 1.2 yrs
12th
|
3.0 yrs
38th
|
4.0 yrs
62nd
|
| Liabilities / assets | 40.9%
25th
|
51.6%
50th
|
39.0%
12th
|
| IS credit model rating | AA+ | BBB | A |
| Implied credit spread (bps) | 65
0th
|
275
50th
|
150
25th
|
Efficiency
11 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| Asset turnover | 0.54
62nd
|
0.53
50th
|
0.43
12th
|
| Fixed asset turnover | 1.15
50th
|
1.24
62nd
|
1.83
75th
|
| Inventory turnover | 12.2
100th
|
3.3
62nd
|
2.1
12th
|
| Receivables turnover | 11.9
75th
|
3.4
25th
|
2.2
12th
|
| Days sales outstanding | 31 days
25th
|
109 days
75th
|
164 days
88th
|
| Days inventory outstanding | 30 days
0th
|
110 days
38th
|
171 days
88th
|
| Days payables outstanding | 54 days
50th
|
85 days
75th
|
152 days
100th
|
| Cash conversion cycle (days) | 7 days
0th
|
134 days
62nd
|
183 days
88th
|
| Capex / revenue | 13.8%
100th
|
7.5%
29th
|
3.3%
14th
|
| Capex / depreciation | 1.20
71st
|
0.89
57th
|
0.47
14th
|
| Operating expense ratio | 4.2%
12th
|
11.7%
38th
|
24.3%
88th
|
Cash flow & earnings quality
7 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| Operating cash flow / net income | 1.42
29th
|
1.78
43rd
|
1.20
0th
|
| FCF / net income | 0.91
57th
|
0.89
29th
|
0.62
14th
|
| FCF / operating cash flow | 64.2%
71st
|
49.8%
43rd
|
51.9%
57th
|
| Capex / operating cash flow | 35.8%
29th
|
50.2%
57th
|
48.1%
43rd
|
| Accruals ratio | -6.1%
25th
|
-3.5%
75th
|
-0.5%
100th
|
| Sloan accruals ratio | 1.7%
75th
|
-3.2%
50th
|
-5.2%
25th
|
| Earnings quality score (0-1) | 0.75
0th
|
1.00
71st
|
1.00
71st
|
Scores & forensic checks
15 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| IS score | 83
100th
|
63
62nd
|
41
25th
|
| IS profitability | 90
100th
|
41
62nd
|
54
75th
|
| IS growth | 76
100th
|
63
62nd
|
23
12th
|
| IS value | 84
100th
|
82
75th
|
39
12th
|
| IS momentum | 97
100th
|
90
75th
|
56
12th
|
| IS risk (safety) | 90
100th
|
50
25th
|
65
75th
|
| IS quality | 92
100th
|
76
62nd
|
75
50th
|
| IS balance sheet | 81
88th
|
57
38th
|
73
75th
|
| IS earnings quality | 79
75th
|
68
38th
|
73
50th
|
| IS cash flow | 71
88th
|
57
50th
|
33
25th
|
| Piotroski F-score (0-9) | 9
100th
|
8
62nd
|
5
0th
|
| Altman Z-score | 3.5
100th
|
1.9
25th
|
2.9
88th
|
| Beneish M-score | −2.53
75th
|
−2.57
62nd
|
−2.61
38th
|
| Ohlson O-score | −9.99
12th
|
−8.86
38th
|
−9.17
25th
|
| IS credit score | 91
100th
|
59
50th
|
74
75th
|
Size (TTM)
8 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| Market cap | $18.3B
88th
|
$34.0B
100th
|
$8.6B
75th
|
| Revenue | $7.7B
62nd
|
$28.1B
100th
|
$17.8B
88th
|
| EBITDA | $4.2B
88th
|
$6.3B
100th
|
$3.2B
75th
|
| Net income | $2.1B
88th
|
$2.4B
100th
|
$1.0B
75th
|
| Free cash flow | $1.9B
88th
|
$2.1B
100th
|
$629.0M
75th
|
| Total assets | $15.1B
62nd
|
$53.6B
100th
|
$41.6B
88th
|
| Shareholders' equity | $5.7B
50th
|
$25.9B
100th
|
$25.2B
88th
|
| Employees | 2,900
25th
|
25,500
100th
|
21,500
88th
|
Price performance
9 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| 1 day | +0.9% | +2.5% | 0.0% |
| 1 week | +8.4% | +5.7% | −2.7% |
| 1 month | −9.7% | −9.0% | −84.2% |
| 3 months | −2.1% | +7.0% | −85.2% |
| 6 months | +7.3% | +0.9% | −84.0% |
| Year to date | +51.7% | +12.9% | −81.0% |
| 1 year | +42.4% | +22.6% | −79.1% |
| 3 years, cumulative | +51.9% | +27.5% | −73.5% |
| 5 years, cumulative | +116.7% | +16.4% | −68.5% |
Technicals
4 measures| Measure | CF | NTR | CTVA |
|---|---|---|---|
| RSI 14 | 52.6 | 49.1 | 11.4 |
| From 52-week high | −14.8% | −16.5% | −85.8% |
| From 52-week low | +60.3% | +34.4% | +12.2% |
| Beta | 0.40 | 1.08 | 0.58 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17